CD8A and leukemia: To determine the efficacy of human CD19-BBz/shMCJ-1 CD8 CAR-T cells in killing human leukemia cells expressing CD19, we isolated CD8 cells from 2 healthy donors (H16 and H19) with high MCJ expression.